Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats

Hypertension. 1992 Nov;20(5):596-600. doi: 10.1161/01.hyp.20.5.596.

Abstract

We investigated the role of insulin in salt-sensitive hypertension in Dahl salt-sensitive and salt-resistant rats. The rats were kept in metabolic cages, and sodium intake and urinary sodium excretion were measured. In salt-sensitive rats receiving a 0.3% NaCl diet, sodium retention was significantly greater at weeks 1 and 2 in rats that received an insulin infusion than in those receiving a saline infusion. Mean arterial blood pressure and plasma norepinephrine levels were significantly higher at week 3 in insulin-treated rats than in saline-treated rats (mean arterial pressure, 137 +/- 3 mm Hg versus 119 +/- 3 mm Hg, p < 0.05; plasma norepinephrine, 0.40 +/- 0.02 ng/ml versus 0.27 +/- 0.01 ng/ml, p < 0.05). Insulin did not influence sodium retention, mean arterial pressure, or plasma norepinephrine in salt-resistant rats. Coadministration of an alpha-blocker (bunazosin, 10 mg/kg per day for 3 weeks) in salt-sensitive rats abolished the insulin-induced elevations in mean arterial pressure and sodium retention. When salt-sensitive rats were fed a low salt diet (0.03% NaCl), insulin did not raise mean arterial pressure. Thus, insulin elevated blood pressure only in the salt-sensitive model. The sympathetic nervous system and sodium retention in the early phase of insulin overload may contribute to elevation of mean arterial pressure in this model.

MeSH terms

  • Animals
  • Blood Pressure*
  • Drug Resistance / genetics
  • Hyperinsulinism / blood
  • Hyperinsulinism / physiopathology*
  • Hyperinsulinism / urine
  • Insulin / blood
  • Male
  • Natriuresis
  • Norepinephrine / blood
  • Rats
  • Rats, Inbred Strains
  • Sodium Chloride / pharmacology*

Substances

  • Insulin
  • Sodium Chloride
  • Norepinephrine